[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL COMPOUND

The present invention relates to a novel [1,2,4]triazolo[1,5-a] pyrimidin-yl derivative as inhibitor of phosphodiesterase 2 (PDE2). The invention is also directed to pharmaceutical compositions comprising the compound, to processes for preparing such compound and compositions, and to the use of such...

Full description

Saved in:
Bibliographic Details
Main Authors PETRUS JACOBUS JOHANNES ANTONIUS BUIJNSTERS, WILHELMUS, HELENA IGNATIUS MARIA DRINKENBURG, ABDALLAH AHNAOU, HENRICUS JACOBUS MARIA GIJSEN
Format Patent
LanguageEnglish
Published 15.12.2022
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a novel [1,2,4]triazolo[1,5-a] pyrimidin-yl derivative as inhibitor of phosphodiesterase 2 (PDE2). The invention is also directed to pharmaceutical compositions comprising the compound, to processes for preparing such compound and compositions, and to the use of such compound and compositions for the prevention and treatment of disorders in which PDE2 is involved, such as neurological and psychiatric disorders.
Bibliography:Application Number: MY2018PI00611